Skip to main content

What Is Getting COVID Vaccine Like? Jim Cramer Details His Moderna Experience

Publish date:
Video Rating:
Video Duration:

Johnson & Johnson  (JNJ) - Get Johnson & Johnson Report single-shot vaccine candidate has been shown to be safe and to generate a meaningful immune response in an early phase trial, according to a published report Wednesday.

A single shot of the vaccine “gives sustainable antibodies,” Dr. Paul Stoffels, chief scientific officer at J&J, told CNBC. The results have given the company “confidence” that the vaccine will be effective, Stoffels told CNBC.

In the video above, Jim Cramer breaks down what a third vaccine would mean for the markets as well as his experience receiving the Moderna  (MRNA) - Get Moderna, Inc. Report vaccine. 

Watch: Everything Jim Cramer Is Watching in the Stock Market Thursday

Latest Videos From TheStreet and Jim Cramer:

Related Videos